Altimmune, Inc.
BROAD AND LONG-LASTING INFLUENZA VACCINE
Last updated:
Abstract:
Provided herein are monovalent pharmaceutical compositions (vaccine compositions) and methods for inducing a multi-arm (mucosal, humoral and cell-mediated) immune response and extended seroprotection of at least 12 months post vaccination against influenza virus.
Status:
Application
Type:
Utility
Filling date:
6 Apr 2020
Issue date:
8 Oct 2020